Fmr LLC Gilead Sciences, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 59,955,377 shares of GILD stock, worth $7.07 Billion. This represents 0.39% of its overall portfolio holdings.

Number of Shares

59,955,377

Previous 58,542,842 2.41%

Holding current value

$7.07 Billion

Previous $6.56 Billion 1.33%

% of portfolio

0.39%

Previous 0.44%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$96.91 - $113.0 $137 Million - $160 Million	1,412,535 Added 2.41%	59,955,377 $6.65 Billion
Q1 2025 May 12, 2025	BUY	$89.14 - $117.41 $1.62 Billion - $2.14 Billion	18,223,410 Added 45.2%	58,542,842 $6.56 Billion
Q4 2024 Feb 13, 2025	BUY	$83.95 - $97.9 $601 Million - $701 Million	7,157,113 Added 21.58%	40,319,432 $3.72 Billion
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $978 Million - $1.23 Billion	14,680,161 Added 79.43%	33,162,319 $2.78 Billion
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $56.4 Million - $65.1 Million	893,636 Added 5.08%	18,482,158 $1.27 Billion
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $35.1 Million - $42.8 Million	490,874 Added 2.87%	17,588,522 $1.29 Billion
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $154 Million - $175 Million	-2,104,011 Reduced 10.96%	17,097,648 $1.39 Billion
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $64.3 Million - $70.1 Million	-869,555 Reduced 4.33%	19,201,659 $1.44 Billion
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $63.7 Million - $72.6 Million	-837,868 Reduced 4.01%	20,071,214 $1.55 Billion
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $346 Million - $394 Million	4,470,179 Added 27.19%	20,909,082 $1.73 Billion
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $841 Million - $1.21 Billion	13,498,403 Added 459.05%	16,438,903 $1.41 Billion
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $60,016 - $68,554	1,008 Added 0.03%	2,940,500 $181 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $195 Million - $219 Million	-3,373,564 Reduced 53.44%	2,939,492 $182 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $87.4 Million - $110 Million	-1,509,500 Reduced 19.3%	6,313,056 $375 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $97.6 Million - $111 Million	1,504,295 Added 23.81%	7,822,556 $568 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $190 Million - $205 Million	2,809,204 Added 80.06%	6,318,261 $441 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $223 Million - $243 Million	3,509,057 New	3,509,057 $242 Million

Others Institutions Holding GILD

# of Institutions

2,326

Shares Held

1.02B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $148B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account